Genoscience Pharma   Report issue

For profit Phase 2
Founded: Marseiiles France (2002)
Status: Defunct (2014)

Organization Overview

First Clinical Trial
2018
NCT03316222
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Genoscience Pharma